InvestorsHub Logo

nidan7500

09/30/17 8:20 AM

#122617 RE: tredenwater2 #122591

No wonder the BOD, Missling, and maybe even the SAB have taken the route chosen. Any BP with this technology IMO could not be trusted to bring this drug to market in its entirety.





Agree w/this and have for a while now, in fact they may have little choice considering the possible scope of medical practice "retninking" that certainly must be done if the effectiveness of CNS Homeostasis thesis is proven. IMO, the AVXL policy of "Radio Silence" can best be understood if one assumes the "what if" economic consequences are real. They really have no choice until enough hard results/data are in place. The RWE, new thinking/processes of the NEW FDA will result in prayers WW being answered, IMO.

The brilliance of selecting RETT as the base-Beta trial is dramatically scary. Is this guy REALLY that far out in front of the herd? It would seem so.